Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Department of Justice
Pharma
DOJ sues Regeneron for under-reporting Eylea price to Medicare
In a lawsuit filed after a whistleblower tipoff, the DOJ alleges Regeneron knowingly submitted false Eylea average sales prices to Medicare.
Angus Liu
Apr 11, 2024 11:12am
FTC to review Novo Holdings' Catalent buyout for 30 more days
Apr 8, 2024 11:58am
DOJ probing BioMartin testing programs for Vimizim, Naglazyme
Feb 28, 2024 7:48am
Biogen slapped with DOJ subpoena over foreign operations
Feb 14, 2024 10:58am
AARP challenges Chamber lawsuit targeting IRA price negotiations
Aug 21, 2023 10:26am
DOJ blasts Chamber of Commerce's IRA suit in scathing rebuttal
Aug 16, 2023 11:02am